fbpx
Medical Innovation Exchange

Lyme-light: Pfizer triggers surge in Valneva’s stock with €91M investment to support phase 3 vaccine trial

https://www.fiercebiotech.com/biotech/lyme-light-pfizer-triggers-surge-valnevas-stock-eu91m-investment-support-phase-3-vaccine

Leave a Comment

Your email address will not be published.

Leave the field below empty!

This site uses Akismet to reduce spam. Learn how your comment data is processed.